Daclatasvir dihydrochloride is a complex organic compound used as an active pharmaceutical ingredient. It features a salt-like form with multiple aromatic rings and amide functional groups, and is provided as a research-grade material.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Daclatasvir dihydrochloride?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Daclatasvir
pharmaceutical raw material
Ravidasvir
pharmaceutical raw material
Vistusertib
pharmaceutical raw material
Levofloxacin
pharmaceutical raw material
Pyridostigmine bromide
pharmaceutical raw material
Hyoscyamine
pharmaceutical raw material
Bis(2-methyl-2-propanyl) (2S,2'S)-2,2'-[4,4'-biphenyldiylbis(1H-imidazole-4,2-diyl)]di(1-pyrrolidinecarboxylate)
pharmaceutical intermediate
2-((2S)-Pyrrolidin-2-yl)-5-(4-(4-(2-((2S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)phenyl)phenyl)-1himidazole tetrahydrochloride
pharmaceutical intermediate
The international HS code for Daclatasvir dihydrochloride (CAS 1009119-65-6) is 2933.29.
2933.29
2933 29 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;dihydrochloride
BVZLLUDATICXCI-JMSCDMLISA-N
CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC.Cl.Cl
Sourcing Daclatasvir dihydrochloride?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.